Order Code: C277
Includes: Vitamin D2 (Ergocalciferol), Vitamin D3 (Cholecalciferol), and Total Vitamin D (25-Hydroxycalciferol)
ABN Requirement: No
Synonyms: Vitamin D (D2 and D3); 25-Hydroxycalciferol; 25-OH-D; Cholecalciferol Metabolite
Specimen: EDTA Plasma or Serum
Volume: 0.5 mL
Minimum Volume: 0.2 mL
Container: EDTA (Lavender Top tube) or Gel-barrier tube (SST, Tiger Top)
- Draw and gently invert 8 to 10 times.
- Centrifuge for 10 minutes.
- Pre-squeeze transfer pipet bulb and draw off approximately 2/3 of the upper plasma layer.
Note: This ensures that the buffy coat and red cells remain undisturbed.
- Aliquot plasma into labeled transport tube labeled as “EDTA plasma” and cap tightly. Discard original tube.
- Store transport tube refrigerated at 2-8°C until ready to ship.
- Collect and label sample according to standard protocols.
- Gently invert tube 5 times immediately after draw. DO NOT SHAKE.
- Allow blood to clot 30 minutes.
- Centrifuge for 10 minutes.
Special Instructions: Minimize sample exposure to direct sunlight.
Transport: Store plasma at 2°C to 8°C after collection and ship the same day per packaging instructions provided with the Cleveland HeartLab shipping box.
Ambient (15-25°C): 21 days
Refrigerated (2-8°C): 21 days
Frozen (-20°C): 185 days
Deep frozen (-70°C): 185 days
Causes for Rejection: Specimens other than EDTA plasma or serum; improper labeling; samples not stored properly; samples older than stability limits; or grossly hemolyzed samples.
Methodology: High Turbulence Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS)
Turn Around Time: 3 to 5 days
Relative Risk – Status of Vitamin D Sufficiency
Comment: Overall Vitamin D status is considered deficient at <10.0 ng/mL, insufficient from 10.0-29.9 ng/mL, sufficient from 30.0-80.0 ng/mL, in excess from 80.1-100.0 ng/mL, and at potentially toxic levels when >100.0 ng/mL.
Use: Monitoring vitamin D status
Clinical Significance: Vitamin D is a fat-soluble vitamin and plays a major role in calcium homeostasis. Deficiency of vitamin D and subsequent hypocalcaemia have been linked to many skeletal disorders including osteoporosis. Recent studies have shown evidence that vitamin D is linked to protecting the body from a wide range of diseases. Diseases linked to vitamin D deficiency include stroke, cardiovascular disease, osteoporosis, several forms of cancer, multiple sclerosis, rheumatoid arthritis, type 1 and type 2 diabetes.
Vitamin D exists in two forms, ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3). Vitamin D2 does not occur naturally but is manufactured commercially by irradiating the fungal derived component, ergosterol. Vitamin D2 is the predominant form obtained by prescription in the U.S. Vitamin D3 is produced endogenously from the action of ultraviolet light on the vitamin D precursor, 7-dehydrocholesterol, found in the skin. Vitamin D3 is also found in some foods, over-the-counter vitamin D supplements, and products that contain cholecalciferol. Vitamin D2and D3 are hydroxylated in the liver to form their 25-hydroxy metabolites (25-hydroxyvitamin D2 and 25-hydroxyvitamin D3). These metabolites are further hydroxylated, primarily in the kidneys, to form 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3, which are the highly active and bind to specific vitamin D receptors in target tissues.
The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.